Contrast media are a group of pharmaceuticals that aid in the enhanced delineation of tissues to better direct the diagnosis of disease. These drugs are separated into three major areas of diagnostic imaging: computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound (echocardiographic contrast media).
The report analyzes the contrast media market at the category (CT, MRI, and ultrasound) and subcategory (ionic, non-ionic, barium, paramagnetic and superparamagnetic) levels, highlighting trends and issues affecting the utilization, volume, and value of contrast media at a country level.
Key topics discussed include: the declining utilization of barium contrast agents due to the emergence of endoscopy and CT colonography as favorable alternatives for gastrointestinal imaging, and the effects that recent safety concerns surrounding paramagnetic contrast media may have on the MRI contrast media market.
Competitive assessment: Currently marketed contrast media products and evolving competitive landscape
In-depth analysis of practice patterns and adoption trends of different segments and sub-segments of contrast media
Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications
Other key topics covered include utilization trends, market access, reimbursement considerations, and implications for the overall market
Market share analysis of the competition in different regions
Annualized Individual and cumulative sales units and market revenues for the CT (Ionic, Non-ionic and Barium), MRI (Paramagnetic and Superparamagnetic) and Ultrasound contrast media ( Microbubbles in echocardiography) market from 2012–2022
About The Report
US, France, Germany, Italy, Spain, UK, Japan, Brazil, China and India